Blog - Page 2 of 5578 - QualityStocks

WednesdayMar 11, 2026 1:00 pm

QualityStocksNewsBreaks – US~Observer Investigates Alleged Spoofing Activity Involving Quantum BioPharma (QNTM)

Investigative newspaper examines compliance oversight and market manipulation claims tied to CIBC leadership and a $700M lawsuit The US~Observer, an investigative newspaper focused on exposing misconduct in government, finance and law enforcement, has published an article examining alleged market manipulation involving Quantum BioPharma Ltd. (QNTM). The publication reports that the allegations are part of a $700 million-plus lawsuit currently before the U.S. District Court for the Southern District of New York (Case No. 1:24-cv-07972), where claims of spoofing and related trading activity are under legal review. According to the article by investigative reporter Michael Quiel, the investigation centers on Andrea…

WednesdayMar 11, 2026 12:16 pm

QualityStocksNewsBreaks – Voyager Acquisition Corporation (NASDAQ: “VACHU,” “VACH,” “VACHW”) Reports 99.67% Share Redemptions Ahead Of VERAXA Biotech Merger

Voyager Acquisition (NASDAQ: “VACHU,” “VACH,” “VACHW”) announced that holders of 25,217,315 Class A ordinary shares — representing approximately 99.67% of the shares outstanding — exercised their redemption rights in connection with the company’s planned business combination with VERAXA Biotech AG. Following the redemptions, approximately $885,556 will remain in Voyager’s trust account and 82,685 Class A shares will convert into shares of VERAXA Biotech Holding AG, with the combined company expected to trade on Nasdaq under the ticker “VRXA” upon completion of the transaction. To view the full press release, visit https://ibn.fm/pHv0N About Voyager Acquisition Corp. Voyager is a special purpose acquisition company with a bold…

WednesdayMar 11, 2026 12:00 pm

Positioning for a GPS-Denied Future: SPARC AI Expands U.S. Defense Footprint with Proven Industry Leadership

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. Matt McCrann, former CEO of DroneShield’s U.S. subsidiary, appointed to lead SPARC AI’s North American expansion Overwatch platform delivers software-only GPS-denied targeting and navigation without radar, lidar, or additional hardware Integration with platforms such as Parrot ANAFI GOV/MIL and open flight systems supports scalable defense adoption In modern conflict environments, GPS can no longer be assumed. Jamming, spoofing, and signal denial have transformed positioning and targeting from convenience into a vulnerability, forcing defense agencies to rethink how autonomous systems operate in contested airspace and…

WednesdayMar 11, 2026 11:15 am

Earth Science Tech Inc. (ETST) Is Operating a Diversified Portfolio of Businesses in the Pharmaceutical, Healthcare, Telemedicine and Consumer Markets

Earth Science Tech is a holding company that acquires and manages businesses in several markets, emphasizing execution, capital discipline, and long-term value creation across the company’s various platforms. The company generally focuses on controlling interests in companies where disciplined scaling, regulatory compliance, and operational oversight can drive growth. The team at Earth Science Tech is led by executives with years of experience in areas like finance, business, real estate, digital infrastructure, and others. Earth Science Tech (OTC: ETST), a strategic holding company, operates a portfolio in the pharmaceutical, telemedicine, healthcare and consumer markets. The company strives to build value by…

WednesdayMar 11, 2026 10:30 am

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Appoints TMS, Neuroplasticity Researcher Joshua Brown MD, PhD, as Chief Medical Innovation Officer

Prof. Brown is a leading researcher in Transcranial Magnetic Stimulation (“TMS”) and currently serves as President of the Clinical TMS Society. His work explores how brain stimulation therapies can be enhanced through neuroplasticity-focused medications, including D-cycloserine, a component of NRx’s investigational drug NRX‑101. Brown previously received funding from the Defense Advanced Research Projects Agency (“DARPA”) to study treatments for military personnel suffering from Post-Traumatic Stress Disorder (“PTSD”). NRx is investigating a treatment approach combining ketamine, TMS, and hyperbaric oxygen in patients with PTSD and depression, with trials planned through its HOPE Therapeutics clinic network. The appointment reflects NRx’s evolving strategy…

WednesdayMar 11, 2026 10:00 am

QualityStocksNewsBreaks – Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) (FSE: 4LF0) Reports High-Grade Rare Earth Results From Turvolândia Project

This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising. Canamera Energy Metals (CSE: EMET) (OTCQB: EMETF) (FSE: 4LF0) reported positive assay results from the first 27 of 55 completed auger holes at its Turvolândia rare earth project in Minas Gerais, Brazil, highlighted by hole TUV-AUG-014 returning 3,255 ppm total rare earth oxide over 13 meters from surface, including 5,486 ppm over 3 meters and a peak grade of 6,431 ppm over 1 meter. The company said results from the eastern grid indicate the potential for an ionic clay-hosted rare earth system spanning…

WednesdayMar 11, 2026 9:46 am

QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) CEO Nate Bradley To Present Tokenized Legacy Platform At Luminary 2026 During Oscars Weekend

Datavault AI (NASDAQ: DVLT) announced that CEO Nathaniel “Nate” Bradley will deliver a featured presentation at Luminary 2026 — Film, AI, Music and Crypto Innovators on March 14 at the Beverly Center in Los Angeles as part of Oscars Weekend programming. Bradley will introduce the company’s Tokenized Legacy(TM) platform, a blockchain-based infrastructure designed to enable athletes, musicians and entertainers to permanently manage and monetize name, image and likeness rights through transparent on-chain licensing and automated royalty payments, while the event will also feature demonstrations of Datavault’s ADIO(R) audio data transmission technology and highlight the company’s broader expansion across sports, entertainment and digital asset ecosystems. To…

WednesdayMar 11, 2026 9:45 am

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Prepares for Near-Term Transition from Exploration to Gold Production

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising. Quebec-based LaFleur Minerals is preparing to move from exploration and development to final execution of its gold production strategy, at its sites in the renowned Abitibi Greenstone Belt of eastern Canada LaFleur released results of a positive Preliminary Economic Assessment (“PEA”), guiding its robust production plans for the Swanson Gold Deposit The Swanson Gold Deposit has an updated indicated and inferred mineral resource estimate of 227koz of contained gold Gold’s meteoric rise from around $2,000 per ounce four years ago to the market demand…

WednesdayMar 11, 2026 9:30 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Launches New Growth Strategy Focused On Neurology And Oncology Pipeline Expansion

CNS Pharmaceuticals (NASDAQ: CNSP) announced a new corporate growth strategy aimed at building a high-value pipeline in neurology and oncology through the acquisition or in-licensing of preclinical and clinical-stage therapeutic assets. Following a comprehensive strategic review incorporating clinical probability-of-success modeling, regulatory pathway analysis and market assessments, the company said it will prioritize programs with differentiated mechanisms, clear development pathways and strong commercial potential, while preparing legacy assets TPI 287 and berubicin for potential out-licensing to focus resources on advancing a new acquisition-driven pipeline. To view the full press release, visit https://ibn.fm/MutVR About CNS Pharmaceuticals, Inc. CNS Pharmaceuticals is a clinical-stage…

WednesdayMar 11, 2026 9:20 am

QualityStocksNewsBreaks – Renewal Fuels, Inc. (OTC: RNWF) Appoints Sebastian Hoyos Chief Revenue Officer To Lead Commercial Strategy For Texatron Fusion Platform

Renewal Fuels (OTC: RNWF) announced the appointment of Sebastian E. Hoyos as chief revenue officer, where he will lead the company’s commercial strategy as it advances development of its Texatron(TM) fusion energy platform. Hoyos brings more than 15 years of experience structuring complex energy transactions and long-term contracted power agreements across U.S. and international electricity markets, including negotiating more than 200 solar and storage contracts and managing large renewable energy portfolios for organizations such as Walmart, ENGIE Impact and Duke Energy. The company said his expertise in power purchase agreements and corporate energy procurement will support efforts to build revenue-generating…

Site Search

Company Search